Recombinant Human TRAIL Protein, >95% SDS-PAGE, high purity

Features and benefits
  • Expression System: E. coli
  • Accession #: P50591
  • Protein Tag: No tag
  • Bioactivity: Measured by its ability to induce apoptosis in Jurkat cells (Human T Lymphocyte Cells). The ED₅₀ for this effect is typically <12ng/mL.
  • Endotoxin Concentration: <0.1 EU/μg
Item Number
rp152616
Grouped product items
SKUSizeAvailabilityPrice Qty
rp152616-10μg
10μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$39.90
rp152616-25μg
25μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$69.90
rp152616-100μg
100μg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$269.90
rp152616-1mg
1mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$1,279.90

Animal Free, >95% SDS-PAGE, Active, E.coli, No tag, Arg115-Gly281

Basic Description

Product NameRecombinant Human TRAIL Protein, >95% SDS-PAGE, high purity
SynonymsApo-2 ligand | Apo-2L | Protein TRAIL | TNF-related apoptosis-inducing ligand
GradeActiBioPure™, Animal Free, Azide Free, Bioactive, Carrier Free, High Performance
Product Description

Purity

>95% SDS-PAGE.


Function

Cytokine that binds to TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and possibly also to TNFRSF11B/OPG. Induces apoptosis. Its activity may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4 and TNFRSF11B/OPG that cannot induce apoptosis.

Specifications & PurityActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, High performance, ≥95%(SDS-PAGE)
Purity>95% SDS-PAGE
BioactivityMeasured by its ability to induce apoptosis in Jurkat cells (Human T Lymphocyte Cells). The ED₅₀ for this effect is typically <12ng/mL.
Endotoxin Concentration<0.1 EU/μg
Expression SystemE. coli
SpeciesHuman
Amino Acids115-281 aa
SequenceRERGPQRVAAHITGTRGRSNTLSSPNSKNEKALGRKINSWESSRSGHSFLSNLHLRNGELVIHEKGFYYIYSQTYFRFQEEIKENTKNDKQMVQYIYKYTSYPDPILLMKSARNSCWSKDAEYGLYSIYQGGIFELKENDRIFVSVTNEHLIDMDHEASFFGAFLVG
Protein TagNo tag
Protein LengthProtein fragment
Accession #P50591
SourceRecombinant
Predicted molecular weight19.5 kDa

Images

Recombinant Human TRAIL Protein (rp152616)-Protein Bioactivity
Measured by its ability to induce apoptosis in Jurkat cells (Human T Lymphocyte Cells). The ED₅₀ for this effect is typically <12ng/mL.


Recombinant Human TRAIL Protein (rp152616)-SDS-PAGE
3μg/lane of Recombinant Human TRAIL was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing a band at 17.7 kDa.

Product Specifications

FormLyophilized
ReconstitutionAfter receiving lyophilized powder protein, centrifuge first, and then redissolve with deionized water to the purposed concentration.
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStable for 12 months from the date of receipt of the product under proper storage andhandling conditions. Avoid repeated freeze-thaw cycles.

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeDateItem
ZJ23F0400113Certificate of AnalysisApr 08, 2023 rp152616
ZJ23F0400112Certificate of AnalysisApr 08, 2023 rp152616
ZJ23F0400111Certificate of AnalysisApr 08, 2023 rp152616
ZJ23F0400110Certificate of AnalysisApr 08, 2023 rp152616

Related Documents

References

1. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K et al..  (2004)  Complete sequencing and characterization of 21,243 full-length human cDNAs..  Nat Genet,  36  (1): (40-5).  [PMID:14702039] [10.1021/op500134e]
2. Pitti, R M RM and 5 more authors..  (1996)  Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family..  The Journal of biological chemistry,    (31):   [PMID:8663110]
3. Wiley, S R SR and 9 more authors..  (1995)  Identification and characterization of a new member of the TNF family that induces apoptosis..  Immunity,      [PMID:8777713]
4. Cha, S S SS and 7 more authors..  (1999)  2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity..  Immunity,      [PMID:10485660]
5. Mongkolsapaya, J J and 6 more authors..  (1999)  Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation..  Nature structural biology,      [PMID:10542098]
6. Hymowitz, S G SG and 7 more authors..  (1999)  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5..  Molecular cell,      [PMID:10549288]
7. Muzny, Donna M DM and 113 more authors..  (2006)  The DNA sequence, annotation and analysis of human chromosome 3..  Nature,    (27):   [PMID:16641997]
8. Schnepple, David J DJ and 11 more authors..  (2011)  Isolation of a TRAIL antagonist from the serum of HIV-infected patients..  The Journal of biological chemistry,    (14):   [PMID:21859711]
9. Bordoli, Mattia R MR and 14 more authors..  (2014)  A secreted tyrosine kinase acts in the extracellular environment..  Cell,    (28):   [PMID:25171405]
10. Ramamurthy, Vidhyashankar V and 9 more authors..  (2015)  The structure of the death receptor 4-TNF-related apoptosis-inducing ligand (DR4-TRAIL) complex..  Acta crystallographica. Section F, Structural biology communications,      [PMID:26457518]

Solution Calculators